Skip to main navigation
Logo Logo Logo
  • Home
  • About Us
    • Our Team
    • Board of Directors
    • Advisory Board
  • Science
    • Our Approach
    • Indications
    • Pipeline
      • RE104
      • RE200s
    • Publications
  • INVESTORS
    • Corporate Overview
    • Events & Presentations
    • Stock Info
      • Stock Quote & Chart
      • Analyst Coverage
    • Financials & Public Filings
      • SEC Filings
      • SEDAR Filings
      • Quarterly Results
    • Governance
      • Governance Documents
      • Management Team
      • Board of Directors
      • Committee Composition
      • Whistleblower Portal
    • Resources
      • FAQs
      • Email Alerts
      • Investor Contacts
  • IN THE NEWS
    • Press Releases
    • In The Media
  • Contact Us
  • Home
  • About Us
    • Our Team
    • Board of Directors
    • Advisory Board
  • Science
    • Our Approach
    • Indications
    • Pipeline
      • RE104
      • RE200s
    • Publications
  • INVESTORS
    • Corporate Overview
    • Events & Presentations
    • Stock Info
      • Stock Quote & Chart
      • Analyst Coverage
    • Financials & Public Filings
      • SEC Filings
      • SEDAR Filings
      • Quarterly Results
    • Governance
      • Governance Documents
      • Management Team
      • Board of Directors
      • Committee Composition
      • Whistleblower Portal
    • Resources
      • FAQs
      • Email Alerts
      • Investor Contacts
  • IN THE NEWS
    • Press Releases
    • In The Media
  • Contact Us

SEC Filing Details

Document Details

Form
6-K
Filing Date
Jan 9, 2023
Document Date
Jan 9, 2023
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
Reunion Neuroscience Inc.
Issuer
REUNION NEUROSCIENCE INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

© 2023 Reunion Neuroscience Inc.
All Rights Reserved.

Privacy Policy